Vaccines

Companies Vaccines

SIRION BIOTECH GmbH, Germany

SIRION Biotech is Europe's leading commercial supplier of viral vectors used for genetic cell modelling, gene target validation and gene therapy- and vaccination studies. Since its foundation in 2007, SIRION’s mission has been to change the paradigm for viral vector supplies. It has the ability to more

ImevaX GmbH, Germany

At ImevaX, short for „immune evasion vaccines“, we developed a vaccine against Helicobacter pylori. This pathogen has a unique mechanism to inhibit the immune system, enabling Helicobacter pylori to infect life-long.Our vaccine uses this mechanism against the pathogen. It disables the bacterial fact more

Virometix AG, Switzerland

Virometix AG is a privately held biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention. In an increasingly global world there is a considerable medical need for vaccines to combat infectious as well as a number of chronic human diseases. Fast gr more

News Vaccines

• Super-antibody strategy for universal vaccines
  

  New influenza vaccines are required every autumn, because the viruses constantly change the components to which our immune protection responds. Medical research is focusing on universal vaccines that target more stable parts of the viruses. This new generation of broadly neutralising antibodies is p more

• Plant protection: Researchers develop new modular vaccination kit
  

  Simple, fast and flexible: It could become significantly easier to vaccinate plants against viruses in future. Scientists at Martin Luther University Halle-Wittenberg (MLU), the Leibniz Institute of Plant Biochemistry (IPB) and the National Research Council in Italy (CNR) have developed a new method more

• Viral HIV vaccine gives durable protection against 'death star' strain

  Among HIV researchers, one seemingly indestructible HIV-like strain has earned the nickname "death star." That's due to the strain's reputation for killing off hopes for potential vaccines and immunotherapies that could prevent the disease. A team at the Scripps Research Florida campus reports succe more

Infographics Vaccines

A Summary of Common Vaccine Components

The recent measles outbreak in the US has once again provoked discussion over vaccinations, and why some parents choose not to vaccinate their children despite the benefits of doing so. Whilst not the only factor, part of the blame lies with misinformation about the chemical composition of vaccines more

Publications Vaccines

• Viruses, Vol. 10, Pages 347: Protection against Virulent Infectious Bronchitis Virus Challenge Conferred by a Recombinant Baculovirus Co-Expressing S1 and N Proteins

  Viruses, Vol. 10, Pages 347: Protection against Virulent Infectious Bronchitis Virus Challenge Conferred by a Recombinant Baculovirus Co-Expressing S1 and N Proteins Viruses doi: 10.3390/v10070347 Authors: Yuan Yuan Zhi-Peng Zhang Yi-Ning He Wen-Sheng Fan Zhi-Hua Dong Li-Hua Zhang more

• In silico prediction of protein–protein interaction between Glossina m. morsitans (Westwood, 1851) and Trypanosoma brucei (Kinetoplastida: Trypanosomatidae)

  Abstract Trypanosoma brucei is a pathogenic protozoa that causes chronic Human African Trypanosomiasis and African Animal Trypanosomiasis. The pathogenic parasite is transmitted to humans by the tsetse fly, Glossina m. morsitans. Trypanosomiasis control strategies have targeted either the tsetse ve more

• Viruses, Vol. 10, Pages 325: A Simple and Robust Approach for Evaluation of Antivirals Using a Recombinant Influenza Virus Expressing Gaussia Luciferase

  Viruses, Vol. 10, Pages 325: A Simple and Robust Approach for Evaluation of Antivirals Using a Recombinant Influenza Virus Expressing Gaussia Luciferase Viruses doi: 10.3390/v10060325 Authors: Ping Li Qinghua Cui Lin Wang Xiujuan Zhao Yingying Zhang Balaji Manicassamy Yong Yang more